Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate
| Image |  |
|---|---|
| Description | scientific article published on 19 May 2009 |
| Author/s | |
| Publication date | May 19, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |